StockData

Silicon Laboratories vs Synaptics

SLAB and SYNA side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How SLAB and SYNA compare

Silicon Laboratories is the larger company, worth 1.6 times as much as Synaptics ($7.4B against $4.6B).

Silicon Laboratories grew revenue faster over the last twelve months (21.7% versus 11.4% for Synaptics).

Silicon Laboratories keeps more of each dollar of sales as profit, with a net margin of −4.6% compared with −41.0% at Synaptics.

Silicon Laboratories scores higher on the StockData Score (4 against 3 for Synaptics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricSLABSYNA
Size and price
Market cap$7.4B$4.6B
Share price$221.50$117.36
Change, 1 year81.7%82.3%
Change, 5 years15.0%−56.8%
Beta (5Y)0.272.04
Employees1,9301,700
StockData Score
Total score4 (better)3
Valuation score00
Growth score2 (better)1
Performance score00
Health score22
Dividend score00
Valuation
P/S8.6×3.8× (better)
P/B6.8×4.9× (better)
P/FCF–45.3×
FCF yield−0.07%2.2% (better)
Fair value$123.53$93.44
Margin of safety−79.3%−25.6% (better)
Growth
Revenue growth (TTM)21.7% (better)11.4%
Revenue growth, 5Y average9.0% (better)−2.2%
Profitability
Gross margin60.6% (better)44.7%
Operating margin−5.1% (better)−5.6%
Net margin−4.6% (better)−41.0%
FCF margin−0.63%8.5% (better)
Return on equity−3.6% (better)−42.2%
Return on invested capital−4.2%−3.4% (better)
Financial health
Debt / equity–0.90
Interest coverage−47.0×–
Current ratio5.41 (better)1.12
Altman Z-score30.13 (better)3.33
Piotroski F-score66
Dividends and buybacks
Buyback yield–2.0%
Shareholder yield0.00%2.0% (better)
Ownership
Held by institutions93.2%107%
Held by insiders2.2%3.1%
Insider net buying, 12 months−$4.2M (better)−$8.7M
Short interest, % of float5.2%6.4%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.